Chun-Chieh Wang, Wei-Ting Chang, Yen-Hung Lin, Bing-Hsiean Tzeng, Ting-Hsing Chao, Chung-Lieh Hung, Yen-Wen Wu, Cheng-Hsuan Tsai, Wei-Wen Lin, Kuan-Cheng Chang, Hung-Yu Chang, Wen-Chung Yu, Wen-Hwa Wang, Cheng-I Cheng, Tzung-Dau Wang, Charles Jia-Yin Hou, Wen-Jone Chen
Cardiac amyloidosis is one form of systemic amyloidosis caused by abnormal amyloid fibrils deposited in the extracellular space of the myocardium causing heart failure because of restrictive cardiomyopathy and conduction disturbances. The incidence and prevalence of cardiac amyloidosis are higher than previously noted, particularly among special populations. The most common forms of cardiac amyloidosis are light chain and transthyretin amyloid cardiomyopathy. Even though more than 70% of patients with systemic amyloidosis have cardiac amyloidosis, the diagnosis is often delayed, suggesting significant gaps in the knowledge of cardiac amyloidosis and a lack of multidisciplinary teamwork in our daily practice...
July 2023: Acta Cardiologica Sinica